A request begins a review.
Follow a request through Promise Peptides, a U.S. telehealth platform, to see how a licensed provider reviews each one and decides whether a peptide is appropriate. The information here helps you understand that decision point without assuming a prescription follows.
Perform Peptide may earn money when readers become Promise patients.
Begin with the question you actually have
You do not need to turn a recovery concern into a compound choice before talking to a provider. “What does this evidence mean for my circumstances?” is a different starting point from assuming that a particular preparation belongs in your care.
Our product pages explain the substances and their limits. Your medical history, the reason for symptoms and other medicines are not things a guide can interpret for you. A review is where those individual details enter the conversation.
First: follow the relevant information
The linked Promise Peptides pages describe the current U.S. service and the options relevant to this guide. You leave Perform to read that information and submit any request on the service’s own site. Availability there varies by state and by treatment.
The product and goal pages are places to read about the service’s current information. A link is not a prescription, a clinical recommendation or evidence that a product has a lawful access route. The comparison can help you keep a product name separate from the research claim that first caught your attention.
There is a real distinction between an approved medicine and a compounded preparation. Compounding means preparing a medicine for a particular need rather than using a ready-made approved product. Compounded medicines are not FDA-approved; FDA does not assess each preparation’s safety, effectiveness and quality before it is marketed.
Next: a licensed person reviews the request
Promise Peptides routes each request to a licensed U.S. provider, who makes the prescribing decision. It is a telehealth platform, not the pharmacy preparing a medicine. The provider decides whether a peptide is appropriate; a request does not establish that you qualify.
A review needs enough information for an actual clinical decision. The provider may need to clarify your history, medicines or the reason for the request. This guide does not promise a particular visit format, a set of tests, a response time or a prescription. Those details belong to the service and to the clinician making the assessment.
Not everyone who asks qualifies. A decision that a peptide is not appropriate is still a decision within a clinical review. It is not a step to bypass by choosing a different name from a catalogue.
If something is prescribed, understand what it is
When a provider prescribes through Promise Peptides, licensed U.S. compounding pharmacies prepare what is prescribed. That is a separate role from the telehealth platform’s role. The provider and pharmacy remain responsible for the clinical and legal basis of the actual preparation.
Compounded medicines are not FDA-approved. A pharmacy’s licence and a prescription do not erase ingredient restrictions, change a biologic into an ordinary compounded drug or make a preparation the same as an approved brand. The exact product and the legal basis for it need an answer from the people responsible for the care.
The FDA’s explanation of compounding risks includes quality and contamination concerns as well as the absence of premarket review. Those are reasons for a substantive discussion about the preparation, rather than a conclusion based on the word pharmacy alone.
Questions that make the next conversation clearer
- What medical question is the proposed treatment intended to address?
- Which evidence applies to people in my circumstances, rather than animals or a different condition?
- What exactly is the product, and what permits its use through this route?
- What risks, alternatives and follow-up does the provider consider relevant?
These are discussion points, not instructions for taking a medicine. The guide gives no human dosing, administration directions or individual advice. There is no account or patient record to manage here.
Know the boundaries of this route
Promise Peptides holds LegitScript certification. That certification is separate from FDA approval and does not change a medicine’s regulatory status.
The service is for U.S. patients, with state and treatment differences. A certification does not guarantee eligibility, an outcome or FDA approval of a preparation. Readers outside the United States are not being offered an access route through these links.
For an account, service or prescription question, the contact page points to the responsible service. For the reading itself, the references distinguish animal experiments, human trials and FDA records. Keeping those roles clear makes it easier to ask the right person the right question.